Life Sciences

GCA has an extensive network of experts in medicine and the life sciences.

GCA’s Life Sciences division is staffed by senior business development executives who have worked with some of the world’s premier pharmaceutical and medical device companies. GCA is dedicated to professionalism and the active execution of its strategic plans.


GC_Lab_Logo

GCLab™ Is a network of affiliated specialized laboratories providing governments, hospitals and private patients genomic and other specialty tests.

GCLab™ field of expertise includes unique personalized diagnostic tests for:

  • Better cancer therapy
  • Hematologic diseases
  • Gynecologic genetics

All tests conducted by our personalized medicine experts, genetic scientists and physician specialists.

Prevention

  • Personal genetic risk analysis for cancer
  • Preventive measures

Treatment

  • Personalized genetic risk analysis, i.e., Full gene mapping.
  • Genomics of the tumor, Identification of the genetic tumor mutations.
  • Pharmacokinetic treatment
  • Determination of proper medication and suggested treatment model.
  • “Second opinion panel” A panel of specialists to facilitate to aid the physician In determining the best treatment protocol.
  • Treatment protocol developed by panel of senior professors

GMI
GCA recognizes the challenges faced by clinical research centers and academic technology transfer offices, especially in the areas of:

  • Industry /Business Language & Culture.
  • Business Processes & Plans.
  • Decision methodology & professional process.
  • Global business standards and industry criterions.
  • Clinical Q&A Standards in conjunction with industry requirements

Therefore, GCA developed the Global Model Incubator (GMI) venture… based on the following elements:

GMI benefits the clinical and academic research centers by providing:

  • IP funding
  • Research / studies funding
  • Management & operational funding.
  • Joint ventures with appropriate industry partners.
  • Commercialization funding.
  • Overhead contribution.

Thus elevating the commercialization viability while providing significant funding and global industry managerial mentoring…

Business-Model-graphs